Predicción de biomarcadores en mucopolisacaridosis empleando una red metabólica humana

作者: Diego Salazar Barreto

DOI:

关键词:

摘要: Mucopolysaccharidosis (MPS) are lysosomal storage diseases characterized by a deficiency in the enzymes responsible for degradation of glycosaminoglycans (GAG), this leads to their accumulation and onset number pathological processes characteristic disease. The early detection treatment important prevent deterioration quality life patient. Measuring GAG biofluids is universal biomarker these diseases, however, processing analysis laboratory results may become difficult interpret vary with each patient, so new biomarkers would have an impact on diagnosis monitoring which could guarantee health insurance mechanism diseases. In paper presents computational approximation predict biological markers metabolic alterations from flux variation (balance flow variability analysis) human reconstruction recon 2- different types mucopolysaccharidoses.

参考文章(187)
Britt-Marie Carlberg, Ulf Pettesson, Marie-Louise Bondeson, Helena Malmgren, Niklas Dahl, Presence of an IDS-related locus (IDS2) in Xq28 complicates the mutational analysis of Hunter syndrome European Journal of Human Genetics. ,vol. 3, pp. 219- 227 ,(1995) , 10.1159/000472302
Calogera M. Simonaro, Marina D'Angelo, Xingxuan He, Efrat Eliyahu, Nataly Shtraizent, Mark E. Haskins, Edward H. Schuchman, Mechanism of Glycosaminoglycan-Mediated Bone and Joint Disease Implications for the Mucopolysaccharidoses and Other Connective Tissue Diseases American Journal of Pathology. ,vol. 172, pp. 112- 122 ,(2008) , 10.2353/AJPATH.2008.070564
Maccauro G, Scaramuzzo L, Graci C, Leone A, Spinelli Ms, Di Giacomo G, Venanzi E, Perisano C, Schiavone Panni A, Skeletal modifications in mucopolysaccharidoses: an overview. Journal of Biological Regulators and Homeostatic Agents. ,vol. 26, pp. 139- 144 ,(2012)
Morteza Pourfarzam, Fouzieh Zadhoush, Newborn Screening for inherited metabolic disorders; news and views Journal of Research in Medical Sciences. ,vol. 18, pp. 801- 808 ,(2013)
Vijayalakshmi Chelliah, Camille Laibe, Nicolas Le Novère, BioModels Database: a repository of mathematical models of biological processes. Methods of Molecular Biology. ,vol. 1021, pp. 189- 199 ,(2013) , 10.1007/978-1-62703-450-0_10
Saliha Rizvi, Syed T Raza, Faizal Ahmed, Absar Ahmad, Shania Abbas, Farzana Mahdi, None, The role of vitamin e in human health and some diseases. Sultan Qaboos University Medical Journal. ,vol. 14, pp. 157- 165 ,(2014)
A Gal, A Tylki-Szymanska, H Kresse, M Rathmann, M Beck, S Bunge, Mucopolysaccharidosis type II (Hunter syndrome): mutation "hot spots" in the iduronate-2-sulfatase gene. American Journal of Human Genetics. ,vol. 59, pp. 1202- 1209 ,(1996)
Einat B Vitner, Frances M Platt, Anthony H Futerman, None, Common and uncommon pathogenic cascades in lysosomal storage diseases. Journal of Biological Chemistry. ,vol. 285, pp. 20423- 20427 ,(2010) , 10.1074/JBC.R110.134452
John Forman, Domenica Taruscio, Virginia A. Llera, Luis A. Barrera, Timothy R. Coté, Catarina Edfjäll, Désirée Gavhed, Marlene E. Haffner, Yukiko Nishimura, Manuel Posada, Erik Tambuyzer, Stephen C. Groft, Jan‐Inge Henter, , The need for worldwide policy and action plans for rare diseases Acta Paediatrica. ,vol. 101, pp. 805- 807 ,(2012) , 10.1111/J.1651-2227.2012.02705.X
M. Mulder, P. Lombardi, H. Jansen, T.J. van Berkel, R.R. Frants, L.M. Havekes, Low Density Lipoprotein Receptor Internalizes Low Density and Very Low Density Lipoproteins That Are Bound to Heparan Sulfate Proteoglycans via Lipoprotein Lipase Journal of Biological Chemistry. ,vol. 268, pp. 9369- 9375 ,(1993) , 10.1016/S0021-9258(18)98359-6